DARPin drug conjugates

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameDARPin drug conjugates
Drug Alias NameDARPin drug conjugates (Molecular Partners/ImmunoGen)DARPin-DGN549EGFR multi-specific DARPin molecule (Molecular Partners/ImmunoGen)anti-EGFR DARPin drug conjugatePSC-106 +[8] 
ClassificationBiologics
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Partners Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Partners AgImmunogen Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A